Abstracts

333 – Estimating HIV-1 Viremic Time From Reservoir Sequence Diversity With Uncertainty Quantification

Background Accurate estimation of HIV viremic time, or the duration between infection and viral suppression, is valuable for understanding HIV epidemiology, reservoir dynamics, and informing cure trials. Traditional approaches rely on serological assays or CD4 counts, which can lack quantitative precision. Sequence-based estimates using diversity in pre-treatment plasma RNA address this limitation, but are increasingly…

620 – Cancer Incidence and Risk Factors Among People With HIV in REPRIEVE

Background People with HIV (PWH) have an increased cancer risk compared to the general population. Cancer is a leading cause of morbidity and mortality among PWH. An enhanced understanding of cancer incidence and contributing risk factors, particularly among those well -treated on ART, may guide concomitant individual- and population-level preventive interventions. Methods Analyses were performed…

639 – AI Model Using Immune Parameters to Predict Dysplasia and Guide Decisions on Anal Cancer Screening

Background The ANCHOR study demonstrated that aggressive anal cancer screening and treatment can prevent cancer progression. High Resolution Anoscopy (HRA), however, is invasive and resource-intensive, and risk is not evenly distributed among people living with HIV (PLWH). Individuals with poor immune recovery remain at highest cancer risk. Methods We analyzed 400 PLWH from the UW…

652 – Factors Associated With Cardiovascular Disease in Pre- and Post-HIV Acquisition in South Carolina

Background Cardiovascular disease (CVD) is a leading cause of morbidity among people with HIV (PWH). Prior studies typically compare HIV-negative individuals with PWH, but underlying population differences may confound such comparisons. Longitudinal data that track the same individuals before and after HIV diagnosis can better isolate the impact of HIV acquisition on CVD. This study…

1110 – Implementation of a Combination Intervention on Time to HIV Viral Suppression in the Deep South

Background The Southeastern region has the highest HIV incidence and longest times to achieving and sustaining viral suppression (VS) in the U.S. To address these gaps in Alabama, we initiated COAST-AL,  a combination intervention including: data-driven community-based HIV testing, community-based needs assessments to expedite linkage, and a rapid HIV treatment initiation program with the Mobile…

384 – Concerns, Expectations, and Satisfaction Reported by Participants in 2 HIV Cure Trials With ATI

Background Analytical Treatment Interruptions (ATI) are required to test the efficacy of HIV cure strategies. However, they are highly demanding on participants and may lead to psychosocial impact. We evaluated concerns, expectations, and satisfaction in participants in two HIV therapeutic vaccine trials that included ATI.   Methods A total of 72 people with HIV (PWH)…